Optimised platform for complex genome modifications
CRISPR/Cas technology allows the introduction of a wide variety of genetic alterations in a site-specific manner. It facilitates both simple and complex modifications, and ultimately allows creation of disease models for drug discovery and mode of action analyses. Here, we provide examples of OXGENE's streamlined and automated approach to generating high-quality, validated cell models.
Download the resource to continue reading.